Skip to main content
Tagasi

ISO/TR 10993-22:2017

Biological evaluation of medical devices -- Part 22: Guidance on nanomaterials

Üldinfo

Kehtiv alates 14.07.2017
Direktiivid või määrused
puuduvad

Standardi ajalugu

Staatus
Kuupäev
Tüüp
Nimetus
14.07.2017
Põhitekst
ISO/TR 10993-22:2017 describes considerations for the biological evaluation of medical devices that are composed of or contain nanomaterials. In addition, this guidance can also be used for the evaluation of nano-objects generated as products of degradation, wear, or from mechanical treatment processes (e.g. in situ grinding, polishing of medical devices) from (components of) medical devices that are manufactured not using nanomaterials.
ISO/TR 10993-22:2017 includes considerations on the:
-      characterization of nanomaterials;
-      sample preparation for testing of nanomaterials;
-      release of nano-objects from medical devices;
-      toxicokinetics of nano-objects;
-      biological evaluation of nanomaterials;
-      presentation of results;
-      risk assessment of nanomaterials in the context of medical device evaluation;
-      biological evaluation report;
-      nanostructures on the surface of a medical device, intentionally generated during the engineering, manufacturing or processing of a medical device.
The following are excluded from this document:
-      natural and biological nanomaterials, as long as they have not been engineered, manufactured or processed for use in a medical device;
-      intrinsic nanostructures in a bulk material;
-      nanostructures on the surface of a medical device, generated as an unintentional by-product during the engineering, manufacturing or processing of a medical device.
NOTE          Examples of unintentional nanostructures on the surface of a medical device are extrusion draw lines and machining/tool marks.
ISO/TR 10993-22:2017 is intended to provide a general framework and highlights important aspects which need to be considered when assessing the safety of medical devices composed of, containing and/or generating nano-objects. Additionally, the document identifies several common pitfalls and obstacles which have been identified when testing nanomaterials compared to bulk materials or small molecule chemical species. As a technical report (TR), this document represents the current technical knowledge related to nanomaterials. No detailed testing protocols are outlined or provided. This document can serve as a basis for future documents containing detailed protocols with a focus on nanomaterial testing.

Nõutud väljad on tähistatud *

*
*
*
PDF
254,36 € koos KM-ga
Paber
254,36 € koos KM-ga
Standardi monitooring

Teised on ostnud veel

Põhitekst

EVS-EN ISO 10993-10:2013

Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization (ISO 10993-10:2010)
Kehtetu alates 01.03.2023
Põhitekst

EVS-EN ISO 10993-12:2021

Meditsiiniseadmete bioloogiline hindamine. Osa 12: Proovi ettevalmistamine ja etalonained
Uusim versioon Kehtiv alates 01.07.2021
Põhitekst

EVS-EN ISO 10993-18:2020

Meditsiiniseadmete bioloogiline hindamine. Osa 18: Meditsiiniseadme materjalide keemiline iseloomustamine riskihaldusprotsessis
Kehtiv alates 15.06.2020
Põhitekst

EVS-EN ISO 10993-17:2009

Meditsiiniseadmete bioloogiline hindamine. Osa 17: Aine eraldumise lubatud piirmäärade kehtestamine
Kehtetu alates 01.12.2023